Status: Open Not Enrolling
Investigator: Bincy Abraham
Study Coordinator: Mayyadah Al-Sabbagh
Phone: 346.238.0307
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator:
Phone:
The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease. ... Read more >
Status: Open Not Enrolling
Investigator: Bincy Abraham
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
The primary purpose of this study is to evaluate the efficacy and safety of a single intravenous (IV) re-induction dose of approximately 6 milligram per kilogram (mg/kg) ustekinumab in participants with secondary loss of response (LoR) to subcut ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Rosa Maria Barroso Da Costa
Phone: 713.363.7536
The purpose of this study is to compare the incidence of lymphoma in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi versus those treated with thiopurines. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Mayyadah Al-Sabbagh
Phone: 346.238.0307
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease. ... Read more >
Status: Open Not Enrolling
Investigator: Bincy Abraham
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
This open-label extension and safety monitoring study is composed of two parts: Part 1 will evaluate the long-term safety and efficacy of continued etrolizumab treatment in participants with moderately to severely active Crohn's disease who were ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Rosa Maria Barroso Da Costa
Phone: 713.363.7536
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >
